Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8551770 | 0.78 | CYP2D6 (0.40) | ALDH1A1TSHR | |
| SCHEMBL8752278 | 0.76 | — | — | |
| SCHEMBL7153955 | 0.76 | KDM4E (0.30) | KDM4EALDH1A1 | |
| SCHEMBL27873902 | 0.76 | KDM4E (0.32) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL15128324 | 0.73 | ALDH1A1 (0.38) | USP2ALDH1A1LMNAALOX15 | |
| SCHEMBL778020 | 0.73 | ACHE (0.31) | — | |
| SCHEMBL17082701 | 0.72 | — | — | |
| SCHEMBL28508247 | 0.72 | — | — | |
| SCHEMBL12661476 | 0.72 | — | — | |
| SCHEMBL6696178 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117586478-A | Curable composition, cured product thereof, and wafer level lens | 株式会社大赛璐 | 2024-02-23 | — | — | CN | disclosed |
| US-20240059831-A1 | CURABLE COMPOSITION AND CURED PRODUCT OF THE SAME, AND WAFER-LEVEL LENS | DAICEL CORPORATION (JP) | 2024-02-22 | — | — | US | disclosed |
| EP-3738739-B1 | CURABLE COMPOSITION AND CURED PRODUCT FROM SAME | DAICEL CORP (JP) | 2023-03-08 | — | — | EP | disclosed |
| CN-114879286-A | Optical member and optical device provided with same | 株式会社大赛璐 | 2022-08-09 | — | — | CN | disclosed |
| CN-107614562-B | Photocurable composition, cured product using same, and optical component | 株式会社大赛璐 | 2022-06-03 | — | — | CN | disclosed |
| CN-114479010-A | Molded epoxy resin article having special shape, and optical device provided with same | 株式会社大赛璐 | 2022-05-13 | — | — | CN | disclosed |
| EP-3336121-B1 | CURABLE COMPOSITION AND CURED PRODUCT FROM SAME | DAICEL CORP (JP) | 2021-07-28 | — | — | EP | disclosed |
| CN-107922586-B | Curable composition and cured product thereof | 株式会社大赛璐 | 2021-07-23 | — | — | CN | disclosed |
| CN-107849222-B | Curable composition and cured product thereof | 株式会社大赛璐 | 2021-06-11 | — | — | CN | disclosed |
| EP-3336122-B1 | CURABLE COMPOSITION AND CURED PRODUCT FROM SAME | DAICEL CORP (JP) | 2021-06-02 | — | — | EP | disclosed |
| US-20170260323-A1 | CURABLE COMPOSITION AND OPTICAL ELEMENT OBTAINED USING SAME | DAICEL CORPORATION (JP) | 2017-09-14 | — | — | US | disclosed |
| US-20170232695-A1 | SPECIALLY-SHAPED EPOXY RESIN MOLDED ARTICLE, AND OPTICAL DEVICE PROVIDED WITH SAME | DAICEL CORPORATION (JP) | 2017-08-17 | — | — | US | disclosed |
| EP-3196222-A1 | CURABLE COMPOSITION AND OPTICAL ELEMENT OBTAINED USING SAME | Daicel Corporation (JP) | 2017-07-26 | — | — | EP | disclosed |
| EP-3088465-A1 | CURABLE COMPOSITION FOR LENS, AND LENS AND OPTICAL DEVICE | Daicel Corporation (JP) | 2016-11-02 | — | — | EP | disclosed |
| US-20160311968-A1 | CURABLE COMPOSITION FOR LENS, LENS AND OPTICAL DEVICE | DAICEL CORPORATION (JP) | 2016-10-27 | — | — | US | disclosed |
| US-20160122466-A1 | CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND | DAICEL CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-2995632-A1 | CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND | Daicel Corporation (JP) | 2016-03-16 | — | — | EP | disclosed |
| EP-2344451-A2 | SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS | Acucela, Inc. (US) | 2011-07-20 | — | — | EP | disclosed |
| US-20100093865-A1 | SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ACUCELA, INC. (US) | 2010-04-15 | — | — | US | disclosed |
| WO-2010028088-A2 | SULFUR-LINKED COMPOUNDS FOR TREATING OPTHALMIC DISEASES AND DISORDERS | ACUCELA, INC. (US) | 2010-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122466-A1 | CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND | EEF1A1, EEF2, EEF1A2 | KDM4E 435/4885USP2 1699/4885ALDH1A1 296/4885 |
| US-20100093865-A1 | SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS | ALDH1A2, MPST, CLN6 | KDM4E 3778/4885USP2 1760/4885ALDH1A1 314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.